On Tuesday, Organogenesis Holdings Inc (NASDAQ: ORGO) opened higher 3.28% from the last session, before settling in for the closing price of $3.66. Price fluctuations for ORGO have ranged from $2.28 to $6.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 754.67% at the time writing. With a float of $64.14 million, this company’s outstanding shares have now reached $126.85 million.
The firm has a total of 869 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.89%, operating margin of -5.27%, and the pretax margin is -5.29%.
Organogenesis Holdings Inc (ORGO) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Organogenesis Holdings Inc is 49.44%, while institutional ownership is 51.46%. The most recent insider transaction that took place on Jun 05 ’25, was worth 413,625. In this transaction Chief Admin. and Legal Officer of this company bought 142,379 shares at a rate of $2.91, taking the stock ownership to the 837,437 shares. Before that another transaction happened on Jun 04 ’25, when Company’s Chief Admin. and Legal Officer bought 100,863 for $2.82, making the entire transaction worth $284,716. This insider now owns 695,058 shares in total.
Organogenesis Holdings Inc (ORGO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 754.67% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Check out the current performance indicators for Organogenesis Holdings Inc (ORGO). In the past quarter, the stock posted a quick ratio of 3.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 0.20 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Analysing the last 5-days average volume posted by the [Organogenesis Holdings Inc, ORGO], we can find that recorded value of 1.34 million was lower than the volume posted last year of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 87.44%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 28.53%, which indicates a significant decrease from 87.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.82% in the past 14 days, which was lower than the 161.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.63, while its 200-day Moving Average is $3.64. Now, the first resistance to watch is $3.91. This is followed by the second major resistance level at $4.04. The third major resistance level sits at $4.20. If the price goes on to break the first support level at $3.62, it is likely to go to the next support level at $3.46. Should the price break the second support level, the third support level stands at $3.33.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are currently 126,854K shares outstanding in the company with a market cap of 479.50 million. Presently, the company’s annual sales total 482,040 K according to its annual income of 860 K. Last quarter, the company’s sales amounted to 86,690 K and its income totaled -18,840 K.
